STOCK TITAN

Agilent Technologies SVP & CFO receives 11,726 RSUs under 2018 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Agilent Technologies (ticker: A) reported a stock-based award to its Senior Vice President and Chief Financial Officer. On 11/18/2025, the executive received 11,726 shares of common stock in the form of restricted stock units granted under the Agilent Technologies, Inc. 2018 Stock Plan. The award was reported at a price of $0, reflecting that this is an equity grant rather than an open-market purchase.

The restricted stock units will vest in four equal annual installments beginning on November 18, 2026, meaning the executive will receive portions of the shares over four years as long as the vesting conditions are met. This type of compensation is commonly used to align executive incentives with long-term company performance.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Elinoff Adam Stewart

(Last) (First) (Middle)
5301 STEVENS CREEK BLVD

(Street)
SANTA CLARA CA 95051

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President and CFO
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/18/2025 A 11,726 A $0(1) 11,726 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 18, 2026.
/s/ Bret DiMarco, attorney-in-fact for Mr. Elinoff 11/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What executive transaction did Agilent Technologies (A) report in this Form 4?

Agilent Technologies reported that its Senior Vice President and Chief Financial Officer acquired 11,726 restricted stock units of common stock on 11/18/2025.

How many Agilent (A) shares were granted to the CFO and in what form?

The CFO was granted 11,726 shares in the form of restricted stock units under the Agilent Technologies, Inc. 2018 Stock Plan.

What is the vesting schedule for the 11,726 Agilent restricted stock units?

The 11,726 restricted stock units vest in four equal annual installments beginning on November 18, 2026.

Was this Agilent (A) Form 4 transaction an open-market stock purchase?

No. The transaction reflects a grant of restricted stock units at $0, not an open-market purchase, as part of the company’s equity compensation plan.

Under which plan were the Agilent (A) restricted stock units granted?

The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan in compliance with Rule 16b-3.

Who is the reporting person in this Agilent Technologies (A) Form 4 filing?

The reporting person is an officer of Agilent Technologies, serving as Senior Vice President and Chief Financial Officer.
Agilent Technologies Inc

NYSE:A

A Rankings

A Latest News

A Latest SEC Filings

A Stock Data

35.73B
282.31M
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SANTA CLARA